ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Naresh Trehan
Yugal Mishra
Yatin Mehta
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trehan, N.
Right arrow Articles by Jangid, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trehan, N.
Right arrow Articles by Jangid, D. R.

Ann Thorac Surg 1998;66:1113-1118
© 1998 The Society of Thoracic Surgeons


Supplement

Transmyocardial laser as an adjunct to minimally invasive CABG for complete myocardial revascularization

Naresh Trehan, MDa, Yugal Mishra, PhDa, Yatin Mehta, MDa, Dhan Raj Jangid, MDa

a Escorts Heart Institute and Research Centre, New Delhi, India

Address reprint requests to Dr Mishra, Escorts Heart Institute and Research Center, Okhla Rd, New Delhi, 110 025, India
e-mail: (ehirc{at}giasdlOl.vsnl.net.in)

Presented at "Facts and Myths of Minimally Invasive Cardiac Surgery: Current Trends in Thoracic Surgery IV," New Orleans, LA, Jan 24, 1998.

Abstract

Background. To achieve complete myocardial revascularization in patients with diffuse coronary artery disease and patients at high risk if they undergo cardiopulmonary bypass such as severe systemic disease or diffuse arteriosclerosis of the aorta, we have adopted the technique of combining direct coronary artery bypass grafting without cardiopulmonary bypass with transmyocardial laser revascularization.

Methods. From April 1995 to September 1997 this technique was used in 77 patients. Ages ranged from 37 to 85 years with a mean of 56 ± 17 years. Diffuse coronary artery lesions were present in 46 patients, 10 had severely deranged renal function, 7 had diffuse carotid artery lesions, and 7 had aortic arch atheromas. Liver dysfunction was present in 4 patients and severe obstructive airway disease in 3. The mean left ventricular ejection fraction was 0.45 ± 0.05. Midsternotomy approach was used in 65 patients and anterior minithoracotomy in 12. Direct coronary artery bypass grafting without cardiopulmonary bypass was done to the left anterior descending coronary artery or right coronary artery or both. Transmyocardial laser revascularization using a 1,000-W CO2 laser machine was performed on the areas supplied by ungraftable coronary arteries or even in graftable distal targets in the posterolateral or inferior wall in patients who were at high risk if they underwent cardiopulmonary bypass.

Results. The mean number of vessels bypassed was 1.12. One patient died of intractable ventricular arrhythmia in the early postoperative phase. Mean follow-up was 16.6 months. At 12 months 89% of the patients were angina free. Metabolic stress test demonstrated an average increase in exercise tolerance from 5.2 at baseline to 9.7 minutes at 12 months. Myocardial thallium scanning done at 3-, 6-, and 12-month intervals postoperatively revealed that myocardial perfusion in grafted segments had an exponential trend of improvement, and perfusion in transmyocardial laser revascularization segments showed a linear trend in the same period with a total gain of 28.4%.

Conclusions. Transmyocardial laser revascularization is an excellent adjunct to minimally invasive coronary artery bypass grafting to achieve complete myocardial revascularization in patients with graftable vessels in the anterior wall and ungraftable vessels in the posterior and inferior wall. This achieves complete myocardial revascularization without compromising safety in patients who are at high risk if they undergo cardiopulmonary bypass. Minimal morbidity and mortality in the present series revealed that this procedure is safe, and postoperative follow-up of these patients showed significant functional improvement as well as an improvement in myocardial perfusion scan.




This article has been cited by other articles:


Home page
PerfusionHome page
S. W Sutton, M. A Duncan, V. A Chase, B. L Hamman, and E. H Cheung
Perfusion-assisted beating heart support with a miniature extracorporeal circuit and leukocyte filtration: a 58-year-old patient with severe COPD
Perfusion, December 1, 2004; 19(6): 369 - 373.
[Abstract] [PDF]


Home page
Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
, January 1, 2003; 2(2003): 715 - 750.
[Full Text]


Home page
Asian Cardiovascular and Thoracic AnnalsHome page
K. Minami
Surgical Treatments for Endstage Heart Failure Due to Dilated Cardiomyopathy
Asian Cardiovascular and Thoracic Annals, September 1, 2001; 9(3): 159 - 166.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. R. Bridges
Myocardial laser revascularization: the controversy and the data
Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. T. Beranek
Emerging new concepts of myocardial laser revascularization
J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 977 - 977.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
T. M. McLoitghlin JR
Complications of Minimally Invasive Cardiac Surgical Procedures
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 136 - 142.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.